News | August 07, 2009

Study Shows CTA Evaluations Are More Cost Effective than Angiography


August 7, 2009 – Using 64-slice CT coronary angiography can avoid further invasive angiographies, which can add up to significant cost savings, according to a new study in the American Journal of Cardiology (August 2009, vol. 104, issue 4, pages 498-500).

Researchers from the Baylor University Medical Center, Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, said in a real world, clinical setting the negative predictive value of low-risk CTA is very high and exceptionally helpful in predicting freedom from events for up to three years. They said 64-slice CT coronary angiography is being used more often in the evaluation of patients with chest pain and the strength of this test is its high specificity and negative predictive value in exclusion of coronary artery disease (CAD).

However, they say its use remains controversial because there are theoretical risks of radiation, additional costs of the test, and no long-term data to suggest that excluding CAD by use of this test results in positive patient outcomes. A total of 436 patients underwent 64-slice CTA because of chest pain thought to be anginal. Cardiac CT was ordered by the primary physician or cardiologist based on a low to intermediate pretest probability of flow-limiting CAD. A smaller subset of patients initially underwent stress testing but had equivocal findings or continued symptoms that warranted further evaluation.

Of the total patient cohort, 376 had no significant CAD based on CTA results. Of the 60 patients who were believed on CTA to have flow-limiting CAD, 34 (57 percent) ended up having percutaneous coronary intervention or coronary artery bypass grafting. The remaining 26 patients (43 percent) did not have true flow-limiting disease on coronary catheterization and were treated medically. With follow-up of 36 months, all patients with minimal or no disease by CTA were free of events or intervention.

For more information: www.ajconline.org


Related Content

News | Computed Tomography (CT)

July 16, 2024 β€” Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
News | Computed Tomography (CT)

May 1, 2024 β€”In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

Home May 01, 2024
Home
News | Computed Tomography (CT)

April 22, 2024 β€” A new study showed that a non-invasive imaging test can help identify patients with coronary artery ...

Home April 22, 2024
Home
Feature | Computed Tomography (CT) | By Alberto Morales, MD

Cardiac CT scans, recommended by the American College of Cardiology (ACC) and the American Heart Association (AHA) as ...

Home March 20, 2024
Home
News | Computed Tomography (CT)

February 20, 2024 β€” Ultrahigh-spatial-resolution photon-counting detector CT improved assessment of coronary artery ...

Home February 20, 2024
Home
News | Computed Tomography (CT)

HeartFlow is offering a free webinar based on a recent study that measured the ability of the of its roadmap analysis to ...

Home January 15, 2024
Home
News | Computed Tomography (CT)

December 19, 2023 β€” Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro ...

Home December 19, 2023
Home
Feature | Computed Tomography (CT) | By Andrew Michalski, PhD and Rohit Sood MD, PhD

Coronary artery disease (CAD), also known as ischemic heart disease, is the most common heart disease with a prevalence ...

Home December 05, 2023
Home
News | Computed Tomography (CT)

October 26, 2023 β€” HeartFlow, Inc., a leader in non-invasive integrated artificial intelligence (AI) heart care ...

Home October 26, 2023
Home
News | Computed Tomography (CT)

October 13, 2023 β€” Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and ...

Home October 13, 2023
Home
Subscribe Now